In the scientific world, amylin has long played second fiddle to GLP-1. But now, interest is growing. After GLP-1, amylin has become one of the next-biggest targets being explored for weight loss.

Perrigo Company manufactures and markets OTC wellness products. See why I think PRGO stock has solid growth strategies in ...

Fed up with trying to lose weight with cardio? We reveal how to use calisthenics to shed those unwanted pounds and keep them off.

To determine if you're at a healthy weight, the NHS' BMI calculator is a handy tool. The health organisation suggests that ...

Meanwhile someone else gave their own weight loss tip – recommending black coffee to those trying to get in shape. To see if ...

Research shows that following a high-protein diet supports weight loss and can help you avoid regaining the weight after it ...

Hims & Hers offers personalized telehealth services, with a stock price that reflects high-growth potential. See why we ...

As optimism for GLP-1 receptor agonists for weight loss has grown, so too has their use in children. Currently, liraglutide ...

Get caught up on this morning’s news: a new obesity study, the Onion’s Infowars purchase and more in today’s edition of The ...

While Novo Nordisk and Lilly are the undisputed leaders in weight management right now, a number of pharmaceutical companies ...

Has something changed regarding Eli Lilly or Regeneron's thesis, or is the recent dip an excellent opportunity to invest in ...

Shares of pharmaceutical giant Amgen (AMGN) are attempting to bounce back after suffering a steep drop of 7.1% yesterday.